Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CYSTADANE safely and effectively. See full prescribing information for CYSTADANE. CYSTADANE ® (betaine anhydrous for oral solution) Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
CYSTADANE® is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are: Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect
- generic_name
- betaine
- product_names
- betaine
- ndc
- 52276-400, 52276-400-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en